GlassScriptPhysician profile
Lisa Weiss Forbess
NPI 1811952633
$1,063.71
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
See the full distribution for Adult Congenital Heart Disease
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $663 · 2020: $127 · 2023: $25.84 · 2024: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $273.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $790.64 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $47.53 | 2024 | Xarelto |
| Pfizer INC. | $41.90 | 2024 | |
| Novartis Pharmaceuticals Corporation | $39.33 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $33.77 | 2024 | Farxiga, Wainua |
| Philips North America LLC | $25.84 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $23.23 | 2024 | Arcalyst |
| Novo Nordisk INC | $23.07 | 2024 | |
| Impulse Dynamics (USA) INC. | $21.33 | 2024 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.07 | 2024 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Forbess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.